Medica Group PLC
Director / PDMR Shareholding
Medica Group Plc (LSE:MGP), the UK and Ireland market leader in the provision of teleradiology services, has received notification from Mr Kevin Terrins, Business Development Director of Medica, that on 18 June 2021 he purchased a total of 14,295 ordinary shares of 0.2p in the Company ("Shares") at a price of 174.00p per Share.
Following this transaction, Kevin Terrins is beneficially interested in 1,643,943 shares, representing 1.34% of the issued share capital of the Company.
The notification set out below are provided in accordance with the requirements of the UK Market Abuse Regulation and set out more details of the transactions.
| 1
| Details of the person discharging managerial responsibilities / person closely associated
| ||||||||
| a)
| Name | Mr Kevin Terrins | |||||||
| 2
| Reason for the notification
| ||||||||
| a)
| Position/status
| Business Development Director
| |||||||
| b)
| Initial notification /Amendment
| Initial notification | |||||||
| 3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||||||||
| a)
| Name
| Medica Group PLC | |||||||
| b)
| LEI
| 213800B8XE5FUSZF5Z16 | |||||||
| 4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| ||||||||
| a)
| Description of the financial instrument, type of instrument | Ordinary shares of 0.2p
GB00BYV24996 | |||||||
| | | ||||||||
| b)
| Nature of the transaction
| Market purchase | |||||||
| c)
| Price(s) and volume(s) |
| |
| | ||||
| d)
| Aggregated information - Aggrated volume - Price
|
| |||||||
| e)
| Date of the transaction
| 18 June 2021 | |||||||
| f)
| Place of the transaction
| XLON | |||||||
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
